Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-10-19
DOI
10.1016/j.ijcard.2022.10.129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
- (2022) Connie W. Tsao et al. CIRCULATION
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- (2022) Paul A. Heidenreich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction
- (2021) Xiaojing Chen et al. Clinical Research in Cardiology
- Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
- (2021) David D. Berg et al. Circulation-Heart Failure
- The Heart Failure Association Atlas : Heart Failure Epidemiology and Management Statistics 2019
- (2021) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Patients profiling in Heart Failure for tailoring medical therapy A consensus document of the Heart Failure Association of the European Society of Cardiology
- (2021) Giuseppe M.C. Rosano et al. EUROPEAN JOURNAL OF HEART FAILURE
- Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association
- (2021) Alanna A. Morris et al. CIRCULATION
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients
- (2020) Jennifer Cautela et al. EUROPEAN JOURNAL OF HEART FAILURE
- Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
- (2020) Muthiah Vaduganathan et al. LANCET
- Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry
- (2020) Hiroki Kitakata et al. Journal of the American Heart Association
- Longitudinal Titration of Medical Therapy for Heart Failure with Reduced Ejection Fraction: CHAMP-HF Registry
- (2019) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure
- (2019) Steven M. Hollenberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
- (2018) Maria G. Crespo-Leiro et al. EUROPEAN JOURNAL OF HEART FAILURE
- Medical Therapy for Heart Failure With Reduced Ejection Fraction
- (2018) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization
- (2018) Aditi A. Bhagat et al. JACC-Heart Failure
- Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF
- (2017) Michael Böhm et al. EUROPEAN HEART JOURNAL
- Observations on the blood pressure paradox in heart failure
- (2017) Hector O. Ventura et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Estimated Plasma Volume Reduction on Renal Function for Acute Heart Failure Differs Between Patients With Preserved and Reduced Ejection Fraction
- (2015) M. Takei et al. Circulation-Heart Failure
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial
- (2012) Andrew P. Ambrosy et al. AMERICAN HEART JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started